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ahe Society for Cardiovascular Magnetic Resonance
SCMR) held its 2007 meeting from February 2 to February
in Rome, Italy. As has been traditional when it is held in
urope, the meeting was held jointly with the Working
roup for Cardiovascular Magnetic Resonance (CMR) of
he European Society of Cardiology with an expanded
rogram committee to reflect the input of both societies.
eflecting the growing interest in CMR, 885 (an increase of
ver 10% increase from 2006) clinicians and investigators,
echnologists, and nurses attended this year’s meeting. The
rogram itself was larger than ever and featured 9 clinical
essions, 8 “meet the expert” discussions, 5 basic magnetic
esonance science sessions, 4 case discussions, 2 congenital
essions, 2 political sessions, and the annual trainee session.
mong a record number of 546 submitted abstracts, the
eview panel selected 87 abstracts for oral presentations; 13
s moderated posters, and 341 as posters. Additionally, 139
nvited speakers provided state-of-the-art review talks,
iewpoints, and new data. Among this year’s areas of
nterest were CMR of acute myocardial infarction, stem cell
racking, nonischemic cardiomyopathies, molecular imag-
ng, the comparative utility of CMR and cardiac comput-
rized tomography, and interventional CMR.
rom the *Stephenson CMR Centre at the Libin Cardiovascular Institute of Alberta,
niversity of Calgary, Calgary, Alberta, Canada; †University of Virginia Health
ystem, Charlottesville, Virginia; ‡New York University, New York, New York;
Cleveland Clinic Foundation, Cleveland, Ohio; University Hospital, Basel, Swit-
erland; and #Oxford University, Oxford, United Kingdom. Members of the 2007
rogram Committee are listed in the Appendix.m
Manuscript received April 10, 2007; revised manuscript received May 29, 2007,
ccepted June 3, 2007.orkshops
n addition to the introductory physicians’ CMR course
Chair, Dr. Peter Buser, University Hospital, Basel), a
reconference workshop was offered on basic and experi-
ental research in CMR. This session was endorsed by the
nternational Society for Magnetic Resonance in Medicine,
as chaired by Dr. Daniel Sodickson (New York University,
ew York, New York), and addressed the growing interest
n cardiovascular-specific advances of magnetic resonance
maging technologies. Discussions focused on coil technol-
gy, rapid imaging, and metabolic imaging. Special atten-
ion was given to high accelerations afforded by a 128-
lement detector array (1). Dr. Roderic Pettigrew (National
nstitute of Biomedical Imaging and Bioengineering, Be-
hesda, Maryland) placed CMR in the context of various
ew or newly combined imaging modalities aimed at cellu-
ar and molecular imaging. The workshop concluded with
ecognition of the need for intertwined developments in
ngineering, chemistry, and biology to catalyze the cardiac
maging of the future.
A 3-day technologists’ meeting (Chair, Mary Watkins,
ashington University, St. Louis, Missouri) was held
arallel to the main meeting.
linical CMR
MR tissue characterization: myocardial infarction.
he opening plenary session of the meeting was aimed at an
rea for which CMR is particularly well suited: the assess-
ent of myocardial infarction (MI) and its therapy. Car-
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Highlights of the 2007 SCMR Annual Sessions September 4, 2007:983–7diovascular magnetic resonance
is now viewed as a gold standard
for assessment of infarct size and
microvascular obstruction after
acute MI and is increasingly used
in clinical trials involving acute
MI patients and imaging end
points.
After an introductory lecture by
Dr. Volker Schächinger (J. W.
Goethe University, Frankfurt,
ermany), Dr. Dara Kraitchman (Johns Hopkins Univer-
ity, Baltimore, Maryland) underscored the ability of CMR
o track stem cells in the myocardium with various tech-
iques. Dr. Andrew Arai (National Heart, Lung, and Blood
nstitute, Bethesda, Maryland) reviewed unique applications
f CMR in acute MI, specifically T2-weighted imaging of
he area at risk. This development has now been validated in
nimal models and is being studied in human patients. Dr.
hristopher Kramer (University of Virginia, Charlottesville,
irginia) discussed the important prognostic potential of
icrovascular obstruction in acute MI patients identified as
reas of low signal on both early and late gadolinium-
nhanced images.
issue characterization: nonischemic myocardial disease.
wo sessions addressed myocarditis and other nonischemic
ardiomyopathies. The clinical impact of subclinical myo-
ardial disease detected by CMR was debated. Several
linical examples were discussed, including patients with
typical symptoms but nonischemic patterns of myocardial
ate enhancement, later proved by biopsy to have myocar-
itis. Speakers emphasized the increasing body of evidence
or the prognostic value of irreversible myocardial injury as
efined by “late-enhancement” CMR in nonischemic myo-
ardial disease. Excellent prognostic value had already been
hown in patients with otherwise unrecognized MI (2).
dditional provocative findings included that of late en-
ancement in subjects with aortic stenosis (62%) and arterial
ypertension (45%), despite similar magnitudes of left
entricular hypertrophy and the absence of coronary artery
isease (3). Late enhancement has also been visualized in
he atria in cardiac amyloidosis (4). A study in 42 patients
ith arrhythmogenic right ventricular dysplasia interest-
ngly showed that fat infiltration is rarely the only CMR
maging abnormality, with regional right ventricular systolic
ysfunction being more sensitive and specific (5). Dr.
lessia Pepe (Institute of Clinical Physiology, Pisa, Italy)
nd colleagues reported on a multicenter CMR study of
yocardial iron overload and fibrosis in patients with
halassemia intermedia (6). Twenty-three percent of these
atients had evidence for mostly heterogeneous myocardial
ron overload despite normal global T2* values, and 32%
howed myocardial fibrosis.
MR of myocardial ischemia. The recent accumulation
f outcome data for CMR using dobutamine stress, first-
Abbreviations
and Acronyms
CMR  cardiovascular
magnetic resonance
MI  myocardial infarction
MRA  magnetic
resonance angiography
MRS  magnetic
resonance spectroscopyass perfusion, and late enhancement was underscored by a Itudy from Dr. Erica Dall’Armellina (Wake Forest Univer-
ity, Winston-Salem, North Carolina), who showed that
obutamine-stress CMR predicted major cardiac events in
he following 2 to 3 years in patients with reduced ejection
raction and poor echocardiographic windows (7).
MR in acute heart disease. Several speakers reported on
heir initial experience in applying CMR to risk-stratifying
atients with chest pain in the emergency room, including
edicated T2-weighted images and adenosine stress perfu-
ion. Dr. Oliver Strohm (University of Calgary, Alberta,
anada) presented an estimate that in patients with acute
hest pain but absence of elevated troponin or ST-segment
levation, CMR may not only be helpful in establishing the
iagnosis, but may also be more cost-effective than other
maging-based approaches.
MR protocol optimization. A session about clinical
rotocol optimization focused on practical issues for CMR
linicians. Dr. Sven Plein (University of Leeds, Leeds,
nited Kingdom) emphasized the feasibility of performing
comprehensive 1-h “core” CMR exam including cine
unctional imaging, stress and rest perfusion imaging,
hole-heart coronary artery imaging, and late enhance-
ent. Other presentations highlighted real-time cine meth-
ds and 4-dimensional velocity mapping of the thoracic
orta. The advantages of a new “whole-heart” coronary
rtery imaging approach, akin to 3-dimensional (3D) com-
uterized tomographic angiography were emphasized.
ultidetector CT and CMR of coronary arteries. This
ession, cosponsored by the Society of Cardiovascular Com-
uted Tomography reported on the current feasibility,
afety, and diagnostic accuracy of both techniques to assess
oronary artery stenoses. A constructive discussion pointed
ut that, whereas multidetector CT currently offers a higher
iagnostic accuracy in the assessment of coronary artery
tenoses, CMR has advantages over CT in determining
heir hemodynamic relevance and related viability, without
xposing the patient to ionizing radiation or iodinated
ontrast.
MR at 3-T. Several centers reported 3-T stress perfusion
maging to be superior to that at 1.5-T for the detection of
oronary artery stenosis. Dr. Rolf Gebker (German Heart
nstitute, Berlin, Germany) presented a study of 14 patients
emonstrating an overall diagnostic accuracy of 84% (8).
r. Adrian Cheng (Oxford University, Oxford, United
ingdom) reported an accuracy of 90% in 61 patients,
ompared with 82% when using 1.5-T in the same group
9).
ascular CMR. Among the technical innovations and
mprovements in vascular CMR, new approaches to
ontrast-enhanced magnetic resonance angiography (MRA)
ere presented, including 3D contrast-enhanced MRA
ith time-resolved 3D data sets acquired in a second each
nd continuous-table-motion MRA techniques for imaging
he entire pelvic and peripheral arterial tree.
ward session for clinical CMR research. The “Youngnvestigator Award for Clinical CMR Research” session
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September 4, 2007:983–7 Highlights of the 2007 SCMR Annual Sessionsas dedicated to the memory of Dr. Walter Rogers, one of
he founders of the SCMR. His many contributions to the
eld were highlighted in a short eulogy by Dr. Robert
iederman (Allegheny General Hospital, Pittsburgh, Penn-
ylvania) presented before the abstract presentations. Fea-
uring topics such as rapid imaging and post-transplant
maging, the presentations highlighted creative applications
f CMR in a practical fashion. Dr. Hamid Sattar (Brigham
nd Women’s Hospital, Boston, Massachusetts) received
he award for his work on CMR in diabetic patients. His
tudy showed not only that CMR visualized previously
ndetected infarcts, but also that the extent of infarct scar
redicted outcome (10).
Dr. Juan Santos (Stanford University, Stanford, Califor-
ia) won the Poster Prize for his presentation on rapid
ate-enhancement imaging with real-time inversion time
djustments (11). The second poster prize went to Federico
ordini for his work on fully quantitative perfusion image
nalysis (12).
Other topics presented included methods to shorten
ostprocessing and improve reproducibility of methods for
erfusion analysis and diastolic and systolic functional anal-
sis and an imaging algorithm for CMR in the setting of
atients presenting with chest pain syndromes (13). Lucia
a’s (University of Calgary, Alberta, Canada) moderated
oster presentation on the improved interobserver variability
f short-axis left ventricular volumetry by long-axis cross-
eferences sparked debate during the session, particularly
egarding the standard methodology used for defining
ardiac phases and slice localization (14).
xperimental and Basic CMR
arallel imaging. Several speakers emphasized that high
evels of image acceleration are now possible with multiple-
eceiver magnetic resonance systems and multiple-element
ptimized radiofrequency (RF) coil arrays. The latter are
onsidered a key enabling factor for high accelerations,
ogether with prevailing trends toward the use of 32
eceiver channels and high-field imaging (e.g., 3-T and
eyond). Speakers anticipated that single breath hold
hole-heart cine CMR for rapid assessment of cardiac
unction will further improve patient comfort and slice
egistration. The attendees appreciated the combination of
eading-edge technology development (RF coils, pulse se-
uences, image reconstruction) and clinically focused re-
earch and applications (function, perfusion, delayed en-
ancement, angiography).
nterventional CMR. Cardiovascular applications of in-
erventional CMR continue to gain strength as evidenced by
session devoted to new advances. Dr. Timm Dickfield
University of Maryland, Baltimore, Maryland) reported on
he accumulating evidence regarding the clinical potential of
MR-guided radiofrequency ablation. The anatomic detail
f the pulmonary veins from MRA can be used as a road
ap to guide conventional X-ray ablation procedures. New sata on wireless magnetic resonance–active devices with
igh signal-to-noise properties were presented by Dr.
arald Quick (University Hospital, Essen, Germany). Dr.
itus Kühne (German Heart Institute, Berlin, Germany)
ighlighted the importance of using CMR instead of
ultidetector CT in pediatric interventions so as to reduce
onizing radiation exposure. Dr. Ergin Atalar (Bilkent
niversity, Ankara, Turkey) underscored that all magnetic
esonance devices are safe if they are used within preset
evice-specific guidelines along with careful monitoring and
oststudy testing.
ltrahigh-field CMR. This broad-ranging session reflected
he marked expansion in this area that has accompanied
oth the use of small-animal models in cardiovascular research
nd the application of those models in pursuit of molecular and
ellular CMR imaging. Speakers reviewed data on high-field
pplications for murine myocardial perfusion (Dr. David Sos-
ovik, Massachusetts General Hospital, Boston, Massachu-
etts), vulnerable plaque imaging with perfluorocarbon nano-
articles (Dr. Tillmann Cyrus, Washington University, St.
ouis, Missouri), and using ligand-conjugated iron oxide
icroparticles for visualizing vascular inflammation and plate-
et thrombosis (Dr. Robin Choudhury, John Radcliffe Hospi-
al, Oxford, United Kingdom).
ew coil designs. Three trends in modern coil design
ecame obvious: 1) the use of an increasing number of coil
rray elements for parallel detection; 2) the move toward
rogressively higher magnetic field strength; and 3) the
ising interest in parallel transmission with multiple inde-
endent transmitter coils. Dr. Thoralf Niendorf (University
f Aachen, Aachen, Germany) highlighted synergies be-
ween high-field CMR and highly parallel imaging with
ultiple-element detector arrays. The potential use of
arallel transmission systems for selective cardiac excitations
r for the improvement of image homogeneity at high
agnetic field strength was highlighted. Dr. Elliot
cVeigh (National Institutes of Health, Bethesda, Mary-
and) called for improvements to the ergonomic design of
oils, arguing that the trends described earlier in the session
hould spur the development of wireless miniaturized flex-
ble coil arrays that can conform easily to the surface of the
ody or that can be incorporated into interventional devices.
olecular CMR. This session compared molecular imag-
ng of cardiovascular disease with CMR and other tech-
iques, including optical imaging, ultrasound, radiotracers,
nd magnetic resonance spectroscopy. Hybrid approaches
ombining optical imaging with CMR may allow for
anomolar-range sensitivity, multispectral capabilities, and
igh-throughput screening. These attributes complement
he high resolution, excellent contrast, and functional im-
ging properties of CMR.
MR spectroscopy. Two studies addressed the effect of
asting on myocardial triglyceride content and cardiac func-
ion. Both used 1H magnetic resonance spectroscopy (MRS)
o show that caloric restriction leads to a significant increase of
eptal myocardial triglyceride content, correlating with diastolic
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Highlights of the 2007 SCMR Annual Sessions September 4, 2007:983–7ysfunction and increases in plasma free fatty acids (15,16).
esearchers from Tohoku University in Japan used 31P-MRS
o show that B-type natriuretic peptide (BNP) did not corre-
ate significantly with the myocardial phosphocreatine/
denosine triphosphate ratio, whereas log BNP did (17). A
romising tool for in vivo studies of atherosclerosis using
yperpolarization was a new lipid-targeted atherosclerotic
laque-binding molecule, tetrafluoropropylacrylate, which rap-
dly binds to lipid membranes (18).
odent CMR. There is increasing application of CMR
n small animals. The main topics presented included
argeted imaging in atherosclerosis models, molecular
maging in cell therapies/transplant models, and general
echnical developments. Researchers from the Mount
inai School of Medicine, New York, reported on the
pplication of gadolinium-based micelles for plaque char-
cterization, conjugated to macrophage-specific scaven-
er receptor antibodies (19), oxidation-specific epitopes
20), or high-density lipoproteins (21). Dr. Martina McA-
eer (University of Oxford, Oxford, United Kingdom) used
uperparamagnetic microparticle iron oxide-based contrast
gents to target endothelial adhesion molecules in atheroscle-
osis or activated platelets in a mouse model of vascular injury
22). Iron oxide-based CMR contrast markers may play an
mportant role also in monitoring stem cell therapy after
yocardial infarction (23) or for 3D cardiac tissue engineering
24). Technical developments in small-animal CMR included
he application of a coil array and parallel imaging to accelerate
MR at ultrahigh magnetic fields (25).
xperimental vascular CMR. Among the highlights in
ascular CMR were a novel coronary vein imaging sequence
ith improved contrast based on magnetization transfer
26), a dark-blood coronary vessel wall sequence used to
how increased coronary plaque burden in diabetic patients
ith nephropathy as opposed to those without (27), and a
ovel fibrin-targeted contrast agent, suitable for single-
hoton emission computerized tomography as well as 1H-
nd 19F-CMR (28).
ward session for experimental CMR research. The
2007 Young Investigator Award for Experimental CMR
esearch” session was held in honor of Dr. Frank Wiesmann,
D, a young German researcher who had performed land-
ark studies in murine CMR models and sadly passed away in
006. The prize was given to Dr. Emily Waters (Washing-
on University, St. Louis, Missouri) for her work on
9F-MRS of atherosclerosis-associated inflammatory angio-
enesis in aortic valves of rabbits (29).
ongenital CMR
ecognizing increasing clinical applications and interest, 3
lenary sessions were devoted to congenital CMR. A special
ession covered the role of CMR for imaging the right
entricle (RV) for morphology and quantification of global
nd regional function. Dr. Tal Geva (Children’s Hospital,
oston, Massachusetts) emphasized the role of ventriculo- trterial coupling, RV/left ventricle interaction, and RV
yocardial fiber orientation as important variables of car-
iac performance. The important role of CMR in quanti-
atively assessing the systemic RV in dual-chamber circula-
ions was addressed by Dr. David Patton (University of
algary, Alberta, Canada) and in single-ventricle physiol-
gy by Dr. Mark Fogel (Children’s Hospital, Philadelphia,
ennsylvania).
Data on coronary artery imaging at 1.5- and 3-T using a
ree-breathing navigator-gated 3D whole-heart approach in
hildren and adults with an assortment of congenital anom-
lies were presented (30,31). Several abstracts centered
round the assessment of atrial left-to-right shunts, report-
ng new data on CMR for the detection and quantification
f sinus venosus atrial septal defects and partial anomalous
ulmonary venous connections in the patient with RV
nlargement of unknown cause (32) and on CMR guidance
f cardiac catheterization to assess pulmonary vascular
esistance in left-to-right shunt lesions (33).
oung Investigator Award for CMR in Congenital Heart
isease. The “2007 Young Investigator Award for CMR
n Congenital Heart Disease” winner was Dr. Danielle
obbers-Visser (Erasmus University, Rotterdam, the Neth-
rlands), for her work on the abnormal response of single-
entricle patients to dobutamine-stress CMR in patients
fter a Fontan procedure (34).
est Technologist Abstract
ercedes Pereyra (St. Luke’s Hospital, Houston, Texas) won
he prize of the best technologist abstract for her work on
valuation of single-shot CMR for assessing myocardial via-
ility (35).
onclusions
ighlights of the 2007 10th Annual Sessions of the SCMR
nd 6th Annual Meeting of the Working Group for Cardio-
ascular Magnetic Resonance of the European Society of
ardiology were numerous reports on improved CMR tech-
iques, optimized protocols, and an increasing body of evi-
ence for its prognostic value. Tissue characterization by CMR
roves to have a unique potential compared with other ad-
anced imaging modalities. Technical advances in coil design
nd parallel imaging as well as convincing data on 3-T CMR
pen new fields for research and clinical applications. Cardio-
ascular magnetic resonance for interventions and for meta-
olic imaging is emerging.
The 2008 Annual Sessions will be held from January 31
o February 3, 2008, in Los Angeles, California.
Additional details on previous and future meetings can be
ound on the SCMR website (www.scmr.org).
cknowledgments
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